|[March 10, 2014]
Arrowhead to Present at Barclays Global Healthcare Conference
PASADENA, Calif. --(Business Wire)--
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical
company developing targeted RNAi therapeutics, today announced that
President and CEO, Christopher Anzalone, Ph.D., will present at the
Barclays Global Healthcare Conference on Thursday, March 13, 2014 at
8:00 a.m. EDT at the Loews Hotel in Miami, Florida.
A live webcast of the presentation can be accessed by visiting the News
& Events section of the company's website, http://www.arrowheadresearch.com/pesentations.
A replay will also be archived on the website.
About Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing
targeted RNAi therapeutics. The company is leveraging its proprietary
drug delivery technologies to develop targeted drugs based on the RNA
interference mechanism that efficiently silence disease-causing genes.
Arrowhead technologies also enable partners to create peptide-drug
conjugates that specifically home to cell types of interest while
sparing off-target tissues. Arrowhead's pipeline includes clinical
programs in chronic hepatitis B virus and partner-based programs in
obesity and oncology.
For more information please visit http://www.arrowheadresearch.com,
or follow us on Twitter (News - Alert) @ArrowRes.
To be added to the Company's email list to receive news directly, please
send an email to email@example.com.
[ InfoTech Spotlight's Homepage ]